x |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
o |
TRANSACTION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
For
Quarter Ended:
|
Commission
File Number:
|
March
31, 2007
|
0-7722
|
DELAWARE
|
061034587
|
(State
or other jurisdiction of
|
(IRS
Employer Identification
|
Incorporation
or organization)
|
Number)
|
9835
Santa Fe Springs Road
|
Santa
Fe Springs, CA 90670
|
(Address
of Principal Executive Offices) (Zip
Code)
|
(562)
906-8455
|
(Registrant's
telephone number, including area
code)
|
PART
I FINANCIAL INFORMATION
|
|
ITEM
1. FINANCIAL STATEMENTS (Unaudited)
|
|
The
consolidated Financial Statements are set forth at the end of this
document.
|
|
CONSOLIDATED
FINANCIAL STATEMENTS
|
|
Consolidated
Balance Sheet
|
F-1
|
Consolidated
Statements of Operations
|
F-2
|
Consolidated
Statements of Cash Flows
|
F-3
|
Notes
to Consolidated Financial Statements
|
F-4
- F-15
|
ITEM
2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
OPERATIONS
|
3 |
ITEM
3. CONTROLS AND PROCEDURES
|
8 |
PART
II OTHER INFORMATION
|
9 |
ITEM
1. LEGAL PROCEEDING
|
9 |
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
9 |
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
|
9 |
ITEM
4. SUBMISSION OF MATERS TO A VOTE OF SECURITY HOLDERS
|
9 |
ITEM
5. OTHER INFORMATION
|
9 |
ITEM
6. EXHIBITS
|
11 |
-
|
Approximately
$84,000 of interest expense on convertible
note;
|
-
|
Approximately
$292,000 of amortization of debt discounts from beneficial conversion
feature, warrants and a conversion
option;
|
-
|
Approximately
$90,000 of amortization of deferred financing costs related to warrants
and common stock granted to third parties as financing cost on convertible
note;
|
Exhibit 31.1 |
Section
302 Sarbanes Oxley Certification
|
Exhibit 32.1 |
Section
906 Sarbanes Oxley Certification
|
ASSETS
|
||||
Current
Assets
|
||||
Cash
|
$
|
317,806
|
||
Contract
receivables
|
473,693
|
|||
Inventories,
net
|
1,333,056
|
|||
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
872,335
|
|||
Deferred
financing costs, net
|
358,292
|
|||
Prepaid
expenses and other current assets
|
7,404
|
|||
Total
current assets
|
3,362,586
|
|||
Property
and Equipment, net
|
256,529
|
|||
Deferred
Financing Costs, net
|
328,436
|
|||
Total
Assets
|
$
|
3,947,551
|
||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||
Current
Liabilities
|
||||
Bank
Overdraft
|
$
|
34,090
|
||
Accounts
payable and accrued expenses
|
1,199,491
|
|||
Dividends
payable
|
362,800
|
|||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
399,710
|
|||
Notes
payable
|
12,000
|
|||
Convertible
notes payable, net of discount
|
237,223
|
|||
Total
current liabilities
|
2,245,314
|
|||
Convertible
Notes Payable, net of discount
|
210,000
|
|||
Commitments
and Contingencies
|
||||
Stockholders'
Equity
|
||||
Cumulative,
convertible, Series B preferred stock, $1 par value,
|
||||
15,000,000
shares authorized, no shares issued and outstanding
|
||||
(liquidation
preference of $25 per share)
|
-
|
|||
Cumulative,
convertible, Series C preferred stock, $1 par value,
|
||||
75,000
shares authorized, 27,780 shares issued and outstanding
|
||||
(liquidation
preference of $933,000)
|
27,780
|
|||
Cumulative,
convertible, Series D preferred stock, $25 par value,
|
||||
75,000
shares authorized, 11,640 shares issued and outstanding
|
||||
(liquidation
preference of $416,000)
|
291,000
|
|||
Common
stock, $0.10 par value, 50,000,000 shares authorized;
|
||||
12,264,656
shares issued and outstanding
|
1,226,466
|
|||
Subscriptions
receivable
|
(462,500
|
)
|
||
Notes
receivable from stockholders
|
(532,402
|
)
|
||
Deferred
consulting fees
|
(234,092
|
)
|
||
Additional
paid-in capital
|
8,995,064
|
|||
Accumulated
deficit
|
(7,819,079
|
)
|
||
Total
stockholders' equity
|
1,492,237
|
|||
Total
Liabilities and Stockholders' equity
|
$
|
3,947,551
|
2007
|
2006
|
||||||
CONTRACT
REVENUES
|
$
|
3,185,469
|
$
|
1,699,847
|
|||
COST
OF SALES
|
2,000,230
|
1,296,608
|
|||||
GROSS
PROFIT
|
1,185,239
|
403,239
|
|||||
OPERATING
EXPENSES
|
|||||||
Consulting
and other compensation
|
429,363
|
203,058
|
|||||
Salaries
and related
|
116,634
|
64,331
|
|||||
Selling,
general and administrative
|
173,276
|
187,640
|
|||||
TOTAL
OPERATING EXPENSES
|
719,273
|
455,029
|
|||||
OPERATING
INCOME (LOSS)
|
465,966
|
(51,790
|
)
|
||||
OTHER
EXPENSES
|
|||||||
Loss
on forgiveness of debt
|
(11,688
|
)
|
-
|
||||
Derivative
liability expense
|
-
|
(764,762
|
)
|
||||
Interest
expense, including debt discount amortization
|
(465,241
|
)
|
(395,828
|
)
|
|||
TOTAL
OTHER EXPENSES
|
(476,929
|
)
|
(1,160,590
|
)
|
|||
LOSS
BEFORE PROVISION FOR
|
|||||||
INCOME
TAXES
|
(10,963
|
)
|
(1,212,380
|
)
|
|||
PROVISION
FOR INCOME TAXES
|
-
|
-
|
|||||
NET
LOSS
|
$
|
(10,963
|
)
|
$
|
(1,212,380
|
)
|
|
NET
LOSS APPLICABLE
|
|||||||
TO
COMMON STOCKHOLDERS
|
$
|
(10,963
|
)
|
$
|
(924,505
|
)
|
|
Basic
and diluted net loss available to
|
|||||||
common
stockholders per common share
|
.0.00
|
$
|
(0.09
|
)
|
|||
Basic
and diluted weighted average common
|
|||||||
shares
outstanding
|
11,983,543
|
10,803,611
|
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(10,963
|
)
|
$
|
(1,212,380
|
)
|
|
Adjustments
to reconcile net loss to net cash
|
|||||||
provided
by (used in) operating activities:
|
|||||||
Depreciation
and amortization of property and equipment
|
28,578
|
39,028
|
|||||
Amortization
of deferred financing costs
|
89,574
|
57,466
|
|||||
Amortization
of Beneficial Conversion Features and other debt discounts
|
291,667
|
249,123
|
|||||
Amortization
of deferred consulting fees
|
98,977
|
137,039
|
|||||
Estmated
fair market value of common stock issued for consulting services
|
|||||||
and
related change in fair value
|
247,500
|
-
|
|||||
Derivative
liability expense
|
-
|
764,762
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Contracts
receivable
|
(170,151
|
)
|
(625,005
|
)
|
|||
Inventories
|
(212,874
|
)
|
(112,985
|
)
|
|||
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
288,333
|
132,622
|
|||||
Prepaid
expenses and other current assets
|
12,801
|
(2,083
|
)
|
||||
Notes
receivable from stockholders
|
(7,000
|
)
|
-
|
||||
Accounts
payable and accrued expenses
|
8,031
|
(277,456
|
)
|
||||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
(53,201
|
)
|
61,823
|
||||
Net
cash provided (used in) operating activities
|
611,272
|
(788,046
|
)
|
||||
Cash
flows from investing activities:
|
|||||||
Purchases
of property and equipment
|
-
|
(20,000
|
)
|
||||
Net
cash used in investing activities
|
-
|
(20,000
|
)
|
||||
Cash
flows from financing activities:
|
|||||||
Restricted
cash
|
123,898
|
(1,500,000
|
)
|
||||
Bank
overdraft
|
15,318
|
(27,649
|
)
|
||||
Proceeds
of issuance of convertible notes payable
|
-
|
3,800,000
|
|||||
Principal
payments on notes payable
|
(486,000
|
)
|
(774,000
|
)
|
|||
Deferred
financing costs
|
-
|
(422,500
|
)
|
||||
Net
cash (used in) provided by financing activities
|
(346,784
|
)
|
1,075,851
|
||||
Net
increase in cash
|
264,488
|
267,805
|
|||||
Cash
at beginning of period
|
53,318
|
-
|
|||||
Cash
at end of period
|
$
|
317,806
|
$
|
267,805
|
|||
Supplemental
disclosure of non-cash activities:
|
|||||||
Common
stock and warrants issued for deferred financing costs
|
$
|
-
|
$
|
641,790
|
|||
Conversion
of notes payable and interest to common stock
|
$
|
-
|
$
|
157,500
|
|||
BCF
and other debt discount on convertible notes payable
|
$
|
-
|
$
|
3,800,000
|
|||
Debt
discount on notes payable for note extension
|
$
|
-
|
$
|
18,900
|
|||
Waived
cumulative dividends on preferred stock
|
$
|
-
|
$
|
(287,875
|
)
|
· |
The
Company continues its aggressive program for selling inventory.
|
· |
The
Company continues to implement plans to further reduce operating
costs.
|
· |
The
Company is seeking investment capital through the public and private
markets.
|
|
Number
of
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
in Years
|
Aggregate
Intrinsic
Value
(1)
|
|||||||||
Vested
|
1,250,000
|
$
|
0.32
|
1.35
|
$
|
--
|
|||||||
Expected
to vest
|
2,000,000
|
$
|
0.20
|
4.62
|
$
|
--
|
|||||||
Total
|
3,250,000
|
$
|
--
|
|
|
Outstanding
Options
|
|||||||||||
|
Shares
Available
for
Grant
|
Number
of
Shares
|
Weighted
Average
Exercise
|
Intrinsic
Value
(1)
|
|||||||||
December
31, 2006
|
1,750,000
|
3,250,000
|
$
|
0.25
|
$
|
130,000
|
|||||||
Grants
|
--
|
--
|
--
|
--
|
|||||||||
Exercises
|
--
|
--
|
--
|
--
|
|||||||||
Cancellations
|
--
|
--
|
--
|
--
|
|||||||||
March
31, 2007
|
1,750,000
|
3,250,000
|
$
|
0.25
|
$
|
--
|
|||||||
Options
exercisable at:
|
|||||||||||||
March
31, 2007
|
1,250,000
|
$
|
0.32
|
|
Weighted
|
||||||
|
Warrants
|
Average
Price
|
|||||
|
|
|
|||||
Outstanding,
December 31, 2006
|
6,403,728
|
$
|
0.57
|
||||
|
|||||||
Granted
|
--
|
--
|
|||||
|
|||||||
Exercised
|
--
|
--
|
|||||
|
|||||||
Cancelled/Terminated
|
(25,000
|
)
|
(0.65
|
)
|
|||
|
|||||||
Total
Outstanding, March 31, 2007
|
6,378,728
|
$
|
0.57
|
||||
|
|||||||
Exercisable,
March 31, 2007
|
6,378,728
|
0.57
|
Cumulative
costs to date
|
$
|
3,910,000
|
||
Cumulative
gross profit to date
|
4,123,000
|
|||
Cumulative
revenue earned
|
8,033,000
|
|||
Less
progress billings to date
|
(7,560,000
|
)
|
||
Net
under billings
|
$
|
473,000
|
Costs
and estimated earnings in excess of billings
|
||||
on
uncompleted contracts
|
$
|
873,000
|
||
Billings
in excess of costs and estimated earnings
|
||||
on
uncompleted contracts
|
(400,000
|
)
|
||
Net
under billings
|
$
|
473,000
|
NEW CENTURY COMPANIES, INC. | ||
|
|
|
Date: May 14, 2007 | /s/ DAVID DUQUETTE | |
Name:
David Duquette
|
||
Title:
Chairman, President and
Director
|
|
|
|
Date: May 14, 2007 | /s/ DAVID DUQUETTE | |
Name:
David Duquette
|
||
Title:
Chairman, President and
Director
|
|
|
|
Date: May 14, 2007 | /s/ JOSEF CZIKMANTORI | |
Name:
Josef Czikmantori
|
||
Title:
Secretary and Director
|